Ahead of its proposed initial public offering (IPO),SRL Ranbaxy Ltd, a diagnostics firm owned by the promoters of Ranbaxy Laboratories Ltd, might integrate itself with group drug retailer Fortis HealthWorld Ltd.
The move aims to increase the valuation of the merged entity before it hits the capital market, said a person familiar with the development.
"While Fortis HealthWorld was brought under the Religare brand recently (by changing its name to Religare Wellness Ltd last week), a decision to extend the same to SRL Ranbaxy will be announced soon," he said, requesting anonymity.
A Religare spokesman, however, said, "Though there are synergies between the two businesses, there are no merger plans as of today."
SRL, which runs a chain of pathological laboratories, plans to raise Rs200-250 crore through an IPO. It is part of the Religare group that has interests ranging from technology services and business process outsourcing to health care and financial services
Continue reading: http://www.indiape.com/blog/_archives/2008/8/23/3851782.html
0 comments:
Post a Comment